Confusion ensued when VaxGen of Brisbane, California, released its long-awaited findings on the first test of an AIDS vaccine on 24 February. Over the next few days, VaxGen officials contradicted each other about how the data were analyzed and reported and whether some of the conclusions are statistically significant.